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Because the International Space Station is a closed environment with rotations of 
astronauts and equipment that each introduce their own microbial flora, it is necessary to 
monitor the air, surfaces, and water for microbial contamination. Current microbial 
monitoring includes labor- and time-intensive methods to enumerate total bacterial and 
fungal cells, with limited characterization, during in-flight testing. Although this culture-
based method is sufficient for monitoring the International Space Station, on future long-
duration missions more detailed characterization will need to be performed during flight, as 
sample return and ground characterization may not be available. At a workshop held in 
2011 at NASA's Johnson Space Center to discuss alternative methodologies and technologies 
suitable for microbial monitoring for these long-term exploration missions, molecular-based 
methodologies such as polymerase chain reaction (PCR) were recommended. In response, a 
multi-center (Marshall Space Flight Center, Johnson Space Center, Jet Propulsion 
Laboratory, and Kennedy Space Center) collaborative research effort was initiated to 
explore novel commercial-off-the-shelf hardware options for space flight environmental 
monitoring. The goal was to evaluate quantitative or semi-quantitative PCR approaches for 
low-cost in-flight rapid identification of microorganisms that could affect crew safety. The 
initial phase of this project identified commercially available platforms that could be 
minimally modified to perform nominally in microgravity. This phase was followed by 
proof-of-concept testing of the highest qualifying candidates with a universally available 
challenge organism, Salmonella enterica. The analysis identified two technologies that were 
able to perform sample-to-answer testing with initial cell sample concentrations between 50 
and 400 cells. In addition, the commercial systems were evaluated for initial flight safety and 
readiness. 
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I. Introduction 
Space vehicles must maintain a closed environment with sustainable environmental control systems to recycle air and water. The environment is designed to support rotations of astronauts and equipment, which add to its 
microbial flora. These unique challenges make it necessary to monitor the air, surfaces, and water in the interior of a 
spacecraft for microbial contamination, to identify remediation needs and prevent adverse effects on crew health and 
space flight systems.1-3 Current environmental monitoring procedures require labor- and time-intensive methods to 
enumerate total bacterial and fungal cells during in-flight testing, but characterization capability is limited. 
Enumeration and total coliform testing are performed during flight, but samples are returned to the ground for 
characterization. Samples are typically taken from air, water, and surfaces of the International Space Station (ISS) at 
regular intervals (such as every 3 months), and if microbial cell counts exceed specific limits (e.g., 50 colony-
forming units-CFU--per ml for total bacteria and 0 CFU for coliform bacteria for pre- and in-flight water 
samples), then specific decontamination actions are taken. 3 
Although the current system has proven to be sufficient for the ISS and has protected the crews and vehicle from 
serious defect, multiple subsystems on the ISS have been affected by microbial growth.3 In 2011 , a workshop was 
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held at NASA Johnson Space Center (JSC) to discuss alternative methodologies and technologies suitable for 
microbial monitoring on long-term missions.4 Subject matter experts from industry and academia made 
recommendations suggesting that implementation of molecular-based technologies such as real-time polymerase 
chain reaction (PCR) should be evaluated for supplementation and eventual replacement of the current culture-based 
technologies for long-duration missions. As a result of this recommendation a project was initiated to identify 
commercial technologies that could be used to perform time-critical microbial monitoring ofiSS crew health and the 
water processing and dispensing system. The objective of the project was to perform a market survey of applicable, 
state-of-the-art technologies and develop proof-of-concept testing matrices to evaluate existing commercial 
technologies for use in an in-flight, near-real-time microbial monitoring system. The initial step in this process was 
to evaluate technologies for microbial monitoring of air, water, and surfaces to prevent or minimize impacts on ISS 
operations and crew health. To meet budget and schedule constraints, this effort was initially focused on 
technologies for monitoring potable water quality. The long-term goal of the project is to develop a microbial 
monitoring system that will 
I. Enable rapid assessment of the microbial environment of the ISS, which will lead to expedited 
operational decisions. 
2. Enable monitoring for additional microbes (beyond the current capability). 
3. Reduce the required frequency of sampling. 
4. Enable better and/or more targeted responses to cope with anomalies . 
5. Allow crews to be more independent of the Earth for identification of microbes that affect ISS systems 
and crew health. 
To be considered for the next generation of microbial monitoring hardware to be used on board the ISS, the 
candidates must use quantitative or semi-quantitative PCR technology. The chosen unit will need to function 
properly in a microgravity environment (using such technologies as microfluidics and thermal management), meet 
the appropriate ISS interface and safety requirements, and be autonomous after the sample is inserted into the 
cassette or sample envelope. 
As mentioned previously, a market survey was performed to identify commercially available platforms (see 
Appendix). Three commercially available systems were evaluated during proof-of-concept testing. The proof-of-
concept testing was performed using these systems with a universally available challenge organism (Salmonella 
enterica). In addition, a preliminary qualitative flight assessment was included as part of the overall evaluation. 
I. Cepheid's SmartCycler® is a real-time PCR instrument that has as many as 96 sites and can test 16 
different protocols simultaneously. With an average time-to-results of 20-40 minutes, the SmartCycler 
System can deliver results in less than half the time of a 96-well plate instrument. This high-throughput 
instrument achives faster results with its high thermal conductivity ceramic heater plates, coupled with a 
high-efficiency fan. Some of the other key 
features of this system are easy-to-optimize 
PCR protocols, easy installation and system 
expansion, user-friendliness (plug and play), 
no routine maintenance, and ideal for field 
work because the I-CORE module is a solid-
state optical system with no moving parts. 
2. BioFire Diagnostics (formerly known as 
Idaho Technologies, Inc.) RAZOR® EX is a 
field -portable real-time semi-quantitative 
PCR instrument designed for use by the 
military and first responders for the detection 
and identification of biological agents (i.e., 
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microorganisms) in environmental samples. Figure 1. RAZOR EX water processing pouch. Each 
Raw samples are loaded into a reagent pouch pouch contains 3 targets (Cryptosporidium, Salmonella, 
system containing freeze-dried reagents. Up and Escherichia coli) that are relevant to water systems 
to 12 reactions per single sample or up to 12 monitoring. For this evaluation, the food pouch that 
different samples can be processed in a single detects Campylobacter, Listeria monocytogenes, and 
pouch. BioFire Diagnostics manufactures pre- Salmonella was also utilized. Image from BioFire 
formatted reagent pouches (like the one for Diagnostics website: http://www.biofiredx.com/ 
water testing shown in Fig. 1), or users can RAZOREX/index.html. 
create custom-designed reagent pouches for 
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3. 
use in different environments for the detection of other microorganisms of interest. 
The iCubate 2.0 system 
developed by iCubate, Huntsville, 
AL, is a multiplex semi-
quantitative PCR technology that 
allows a sample to answer 
processing in a self-contained 
cassette. The cassette is pre-
loaded with all required PCR 
reagents, including positive and 
negative 
controls and up to 30 different 
primers, allowing evaluation of 
up to 30 microbial targets in each 
reaction/cassette. The company 
has the ability to custom produce 
cassettes with specified targets 
that could be designed for current 
and future space flight needs. A 
detailed video of the iCubate 
process is available on-line at 
http: //icubate.com/index.php/ 
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The iCubate system performs a Figure 2. iCubate amplification technology. The technology 
multiplex PCR assay using includes the use of specific nested primers during round I of 
amplicon-rescued multiplex PCR amplification, followed by communal primers in round 2 to improve 
and polymerase preference index, sensitivity and decrease time required for amplification. Image from 
an algorithm developed to help iCubate website: www.icubate.com reproduced with permission. 
select the best performing PCR primers based on polymerase preference. A high concentration of target-
specific, nested primers is used in the initial PCR round. Then the amplicon is rescued and a second round 
of PCR is performed by adding fresh communal primers (recognizing the shared tag sequence already 
introduced during the first round of amplification) and enzymes (Fig. 2) . The amplicons are then 
hybridized to an array on a glass slide and array detection is performed using the rotating reader. 
The results of this market research and proof-of-concept testing were used to develop requirements for a 
competitive procurement of a commercial-off-the-shelf PCR unit. The selected PCR unit will be evaluated in much 
more detail to identify risks to the flight qualification of an integrated microbial monitoring system that would be 
used on board the ISS. The long-term goal of this work is to provide crews with a platform capable of in-flight 
automated detection of a wide variety of target compounds . This function will be critical for long-duration missions 
to the moon or beyond where reliance on Earth analysis may not be possible. Just as terrestrial medicine is moving 
toward individualized medicine using multiplex PCR methods for diagnosis,5 space flight medical care will need 
this technology as we move toward exploration-class missions with limited space and sample-return capabilities. 
This project is a starting point for the development of state-of-the art environmental monitoring technology that has 
the potential for future expansion to include medical applications. 
II. Procedures 
Proof-of-concept testing was performed using three PCR-based platforms. The platforms included Cepheid's 
SmartCycler (testing performed by scientists at the Jet Propulsion Laboratory [JPL]); iCubate's iCubate 2.0 (testing 
performed by JSC scientists); and BioFire Diagnostics' RAZOR EX (testing performed by Kennedy Space Center 
[KSC] scientists). The testing organism, conditions, methods, and analysis were consistent across platforms and are 
described in this section. Any platform-unique elements are described in detail. 
A. Test organisms 
The challenge organism was Salmonella enterica (ATCC 14028), because it was the single target that all 
platforms had a· reagent assay kit commercially available to detect. The functional negative control organism was 
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Pseudomonas aeruginosa (ATCC 700888), as it is a common organism that has been recovered from ISS water 
systems. 
Microbial test organisms (S. enterica and P. aeruginosa) were cultured, diluted, and shipped from the KSC 
laboratory to other testing sites (JPL and iCubate facility) . All test organisms were maintained on tryptic soy agar 
(TSA), were transferred weekly, and were no more than three passages removed from the original source. Overnight 
broth cultures were prepared in quadruplicate with a media negative control in 75 mL tryptic soy broth (30 giL) 
incubated in an environmental shaker at 37 ± 2°C at 125 ± 60 rpm for 18-24 hours . The density of viable bacteria 
was checked by serial dilutions (1: 1 0) and plating on TSA. Plates were incubated for 18-24 hours at 3 7 ± 2°C before 
enumeration. 
Optical densities of broth cultures were taken on a spectrophotometer (Genesys 20 ThermoSpectronic, Madison, 
WT) at 590 nm to approximate the bacterial concentration of the inoculum during the incubation in order to identify 
the cellular suspension during mid-log phase in the growth cycle. Once the bacterial suspension reached the 
approximate desired optical density (A.590nm = 0.1 or 1 x 108 cells/mL), the cells were triple rinsed to remove excess 
carbon by centrifuging at 5000 rpm for 5 minutes and decanting the supernatant. The cells were then resuspended in 
IX phosphate buffer saline (PBS). 
Serial dilutions (1: 1 0) of challenge organisms were prepared, ranging from 1 x 105 to 1 x 102 CFU/mL in 
molecular-grade sterile deionized water and/or ISS simulant water (provided by JSC) . ISS simulant water is water 
collected on the ISS from the potable water supply, returned to the Earth and filtered through a 0.2 micron filter. The 
negative operational reagent control (no-template control) consisted of the same components used to make the 
suspensions minus the challenge organisms. The functional negative control was prepared as described above using 
the same concentration of P. aeruginosa bacterial cells . 
After the minimum cellular concentration or lower limit of detection (LLOD) was determined for each platform 
for S. enterica, mixed-culture samples using both challenge organisms at the same concentration were prepared to 
determine if inhibition would occur. The cellular concentrations were varied by platform as indicated below: 
I. SmartCycler - The SmartCycler platform LLOD for S. enterica was determined to be 94 cells/reaction. 
Hence, combinations of S. enterica and P. aeruginosa were tested at concentrations ranging from 1 x I 03 
CFU/mL to I x 106 CFU/mL. 
2. RAZOR - The RAZOR EX platform LLOD for S. enterica was determined to be 5x i02 CFU/mL (50 
cells/reaction). Based on this level of detection, combinations of S. enterica and P. aeruginosa were tested 
at concentrations ranging from 1 x 103 CFU/mL to I x 106 CFU/mL. 
3. iCubate- The LLOD for S. enterica was determined during testing with the iCubate platform to be 1 x J04 
( 400 cells/reaction). As a result, combinations of 1 x 105 CFU/mL and I x 106 CFU/mL of S. enterica and P. 
aeruginosa were used for competitive tesing. 
Salmonella enterica DNA samples were prepared at JPL at a concentration of 1 x 105 CFU/mL and used on each 
platform to determine detection variability. The DNA concentration and purity were evaluated on a NanoDrop 1000 
(Thermo Scientific; Wilmington, DE). 
B. Test methods 
All testing was performed at ambient temperature (25-30°C) unless otherwise noted. 
1. SmartCycler 
The Cepheid SmartCycler System is a rapid thermal cycling PCR instrument platform with real-time 4-
channel detection and solid-st~te optics housed in 16 (expandable to 96) individual modules. The coupling 
of patented SmartTube and SmartCap technology with forced air and ceramic heater plates having high 
thermal conductivity yields average PCR time-to-results of20-40 minutes per sample run. 
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Figure 3. Cepheid's Smartcycler® 
instrument. A 16-well real-time PCR 
instrument with an external computer 
interface and accessories. Image from 
Cepheid (www.cepheid.com) 
2. RAZOREX 
RAZOR testing was performed using 100 J.!L of whole cells or DNA preparations according to the test 
plan. The samples were run in triplicate on each pouch, so a syringe was loaded to a volume of 400 J.!L, 
which was then injected into the pouch through a cannula (Fig. 4) . The pouches are vacuum sealed and 
when the seal is broken, the exact amount required for each sample is loaded into each well. The pouch was 
identified in the system using a barcode scanner, then loaded into the slot to begin a sample run for 25 
minutes. At the start of each run, the pouch is heat sealed to prevent leaks. At the end of each run, the 
results are shown on the display screen of the instrument or can be exported with additional details. 
Figure 4. RAZOR EX hardware. a. 
Portable machine that performs reaction 
and analysis. b. Sample pouch and 
associated sample collection and- injection 
syringes. Image from BioFire Diagnostics 
website: http: //www.biofiredx.com/ 
RAZOREX/index.html . 
3. iCubate 
a. 
The iCubate testing was performed using 40 J.!L of whole cells or I 0 J.!L of DNA loaded into the first well 
of the cassette (Fig. Sa). The cassette was identified in the computer system using a barcode scanner, then 
loaded into the processor to begin a sample run for 4 (DNA) to 6 hours (whole cells including extraction) 
(Fig. Sb). After the run, the cassettes were transferred to the reader for analysis (about 5 minutes) and the 
results generated by the reader were analyzed (Fig. Sc). Each cassette can detect up to 30 different targets 
in addition to positive and negative controls. 
Cassette Processor Reader 
b. 
Figure 5. iCubate hardware. a. Cassette that is pre-loaded with required PCR reagents. b. 
Processor. c. Reader. Images from iCubate website: www.icubate.com reproduced with 
permission. 
C. Analysis and Reporting 
Each platform had a unique standard software analysis package. Each group analyzed the data using the 
platform-associated software and reported the data to the multi-center group. Testing determined that the LLOD for 
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S. enterica was JxJ03 (SmartCycler) to Jx J04 (RAZOR and iCubate) shown in Table I below. Results from the 
testing using a negative control organism (Pseudomonas) showed that the concentration of S. enterica needed to 
detect it in a mixed bacterial sample was one log greater than the concentration needed to detect it in an unmixed 
sample. The ISS water did not contain detectable levels of S. enterica in any of the platforms evaluated. 
Table 1: Results of the proof-of-concept testing demonstrating the ability of each platform tested to 
detect Salmonella enterica at a range of I xI 03 to I x I 04 using between 50 and 400 cells per 
reaction 
Platform Reaction Volume LLOD LLOD of Number of cells 
Salmonella Salmonella enterica needed per 
enterica with Pseudomonas reaction 
(1:1 dilution) 
SmartCycler I J..LL of extracted I xJOj I x )04 94 
DNA 
RAZOR 100 J..LL of whole I x)04 I x JO~ 50 
cells 
iCubate 2.0 40 J..LL of whole I X 104 I X 105 (I X I 04 was 400 
cells or I 0 J..LL not tested) 
DNA III. Discussion and ~onclusions 
The three hardware units tested had the capability to detect ~ 400 cells of S. enterica per sample. Both the 
RAZOR and iCubate technologies used sample-to-answer methodologies in contained systems and were 
recommended for further consideration. Although the SmartCycler was able to detect 94 cells/sample during the 
proof-of-concept testing, it was not considered for further evaluation for flight feasibility for several reasons: 
I . Labor intensive - requires additional extraction procedures, which would increase crew time and amount of 
equipment needed. 
2. Sample containment - the additional sample handling could lead to sample contamination as well as 
amplicon contamination of the environment, compromising all future PCR reactions. 
As a result of the survey and intial testing, the following requirements were developed for future technologies 
and will be used during the competitive request for proposal process to identify technologies that have the ability to 
perform the science requirements needed for operational use during space flight: 
a. Shall be able to simultaneously analyze (quantification or semi-quantification AND identification) at least 
20 targeted microbial populations (viruses, bacteria, and fungi) in water samples using culture-independent 
molecular methodologies. 
b. Shall be automated, requiring minimal crew time to prepare and analyze samples. The equipment shall be 
capable of providing molecular-based sample-to-answer analysis and data output, without the need for the crew 
to assist in the process. 
c. Shall have a detection limit :S 400 cells/sample using :S I 00 J..ll of sample volume per reaction. 
d. If any potentially hazardous liquids are needed, the equipment shall have two levels of containment to avoid 
contamination of the Microbial Monitoring System (MMS) and/or cross-contamination between reagents or 
DNA products . 
e. Shall have the ability to make customized target detection assays. 
f. Shall have portability, which would allow the MMS to be set up quickly and operated without complicated 
setup and assembly. 
g. Shall have the flexibility for the MMS to be used outside of a standard laboratory by non-microbiologists . 
h. Shall be capable of utilizing a molecular identification system designed to support microorganism 
identification and a degree of quantification. 
1. Instrument platform shall consist of a portable thermal cycler with built-in, on-board signal detection, 
analysis, and identification software. 
J. Instrument shall have the capability for connection via USB or other protocol. 
k. Accurate qualitative results for microorganism detection shall be available from the instrument in less than 
six (6) hours. 
I. To minimize requirements for crew time and hazards associated with sample processing on orbit, the 
selected instrument shall have pre-made, pre-mixed reagent mixtures containing all of the reagents and 
reaction components necessary. 
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m. The equipment shall provide analysis of multiplex or multiple targets in one batch of sample containing at least 
four (4) targets. 
n. Reagents shall not require refrigeration during storage. Sample modules shall be able to be stored at room 
temperature for a minimum of six (6) months. 
o. The equipment shall provide data from processed samples. These data shall be readily available to store 
electronically for trend analysis. 
Future work will include submitting a request for quotations that identify any additional current technologies that . 
meet the needs for space flight application, and evaluation of these technologies for potential synergy with other 
efforts being performed by the WetLab2 and MiDASS groups. 
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Appendix 
Market Survey Performed in Spring 2012 Identifying the Current Commercial-Off-the-Shelf 
Quantitative Polymerase Chain Reaction (PCR) Candidates 
3.1.1 
Idaho Technology, Inc. 
RAZOR EX 
Made for field use, the RAZOR 
EX is compact, lightweight, and 
easy to use. Created for first 
responders and rront line 
military .troops, it is easily 
operated while working in 
protective equipment under 
extreme conditions. It can run up 
to 12 reactions per sample 
pouch. Pouches are pre-loaded 
with freeze-dried PCR reagents. 
No refrigeration or freezing is 
necessary. Results are available 
in less than 30 min. 
(Data are from product Web sites and/or published brochures.) 
3.1.2 3.1.3 
Cepheid 
SmartCycler 
Cepheid' s SmartCycler® instrument is a random-
access, modular real-time PCR instrument. Test 
up to 16 different protocols at a time. At the heart 
of the SmartCycler System is the I -CORE® 
module- a reliable, solid-state optical system 
with no moving parts. Each of the standard 16 I-
CORE® modules (expandable to 96) requires no 
warm-up time, no routine maintenance, and no 
normalization dye. The SmartCycler System is 
highly robust and compact, with no moving 
components- ideally suited for mobile use in 
field-testing applications. Sealed, pressurized 
polypropylene SmartTube system designed to 
minimize the risk of amplicon contamination, 
maximize heat transfer, and optimize optical 
sensitivity. Preinstalled software enables each of 
the reaction sites to be operated independently. 
Monitoring of thermal and optical data is in real 
time, ana graphs of temperature, growth and melt 
curves are displayed during data collection. 
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iCubate 
iCubate 2.0 
Includes one Reader, one 
Processor, and a computer with 
preinstalled software. Internal 
and external barcodes scanners 
located throughout the system 
will ensure error rree 
processing and tracking of 
samples. iCubate disposable 
cassettes come pre-loaded with 
specified reagents. Computer 
controlled robotics allow for 
automated sample prep, PCR, 
hybridization and washing 
procedures to be performed. 
Each Processor can run from 
one to four cassettes, each 
containing 12 samples. 
American Institute of Aeronautics and Astronautics 
3.1.4 
Idaho Technology, Inc. 
Film Array* 
User-friendly multiplex PCR all-
in-one system integrates sample 
preparation, amplification, 
detection and analysis into one 
instrument that processes sample to 
results in less than one hour. 
The FilmArray reagent pouch 
stores all the necessary reagents 
rrom sample preparation, reverse 
transcription-PeR, PCR, and 
detection in a rreeze-dried format. 
Prior to a run, the user injects 
hydration solution and unprocessed 
sample into the pouch. The 
FilmArray extracts and purifies all 
nucleic acids rrom the unprocessed 
sample. It then performs a nested 
multiplex PCR. 
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- RAZOR EX Instrument, II lb, 
25.4 x II.4x 19 in. (including 
battery) 
- Battery recharger 
- Battery pack 
24V, 4A power supply 
- USB data cable 
- Air filter assembly 
- Tools: 5.5" Needle-nose 
pliers, lens cleaning solution, & 
tissue 
- Assay Target Pouch 
-Prep Kit: Buffers, syringes, 
RAZOR® EX Instrument 
25.4x iJ.4 x i9 in. II lb 
Sample Pouch 
- Processing Block, 22 lb, 12 x12x 10 in. 
- I-Core Module 
- Smart Tubes 
- Mini centrifuge with SmartTube adapter 
- SmartTube racks 
Cooling block 
- Preinstalled software 
- I 00-240 V ac, 5~0 Hz, 350 W 
- Many of the primers & probes (reagents) must 
be refrigerated. 
- SmartTubes are I x use only (disposable). 
- The optical system has no moving parts to get 
out of alignment or bulbs to be damaged during 
10 
Reader, 75 lb, 
I4x J5 x i4 in. 
Processor, I 02 lb, 
I7 x J7 x i7 in. 
Computer with 
preinstalled software 
iCubate disposable 
cassettes, preloaded 
with specified 
reagents. 
- All 3 components need II 0-
240 V ac, 5A. 
- Reagent trays must be 
refrigerated. 
-?Connectivity to computer 
Processor 
J7 xJ7 x i7 in., 102lb 
Reader 
J4 x J5 x i4 in. 75lb 
American Institute of Aeronautics and Astronautics 
20 lb, IO x i5.5 x6.5 in. 
Windows-based 
instrument control and 
data analysis software 
Barcode reader for data 
input 
Automated qualitative 
analysis and reporting 
Separate advanced 
analysis software 
-90-264 V ac, 10 A 
- Storage at -30°C to 65°C 
- Operating at l5°C to 30°C, 20% 
to 80% humidity 
FilmArray Instrument 
I Ox 15.5 x6.5 in., 20 lb 
- ~~~ 
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·--...-. ... 10-cJM<~ 
l -1"</H< ........ 
. Rt-.Gnt .... cNiwwl 
OC>dUif·~ 
iCore Module 
~~ 
d!'! - ~:~ . 
. f:: :•1:: 1n 1 • • ,•,... ... 
Cassette 
Sample Pouch 
* Proof-of-concept testing was not performed on the FilmArray technology because it was not commercially available at the time testing was initiated. 
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